EUVIMEDEUVIMED entdecken
Crossref

Cystic phenotype and chronic kidney disease in autosomal dominant Alport syndrome

Teresa Bada-Bosch, Angel M Sevillano, María Teresa Sánchez-Calvin, Carmen Palma-Milla, Ignacio Alba de Cáceres, Francisco Díaz-Crespo, Hernando Trujillo iD, Marina Alonso, Clara Cases-Corona, Amir Shabaka iD, Juan Francisco Quesada-Espinosa, José Miguel Lezana-Rosales und 4 weitere

Nephrology Dialysis Transplantation · 31.07.2024 · 39 (8) · 1288-1298

DOI: 10.1093/ndt/gfae002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nephrology Dialysis Transplantation, online erschienen am 04.01.2024. Verfasst von Teresa Bada-Bosch und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Hospital Universitario 12 de Octubre, Madrid, Spain. Hauptthemen laut MEDLINE: Nephritis, Hereditary, Phenotype, Renal Insufficiency, Chronic, Collagen Type IV. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Sociedad Española de Nefrología.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Autosomal dominant Alport Syndrome (ADAS), also known as thin basement membrane disease (TBMD), is caused by pathogenic variants in the COL4A3 and COL4A4 genes. A cystic phenotype has been described in some patients with TBMD, but no genetic studies have been performed. We conducted a genetic and radiologic investigation in a cohort of ADAS patients to analyze the prevalence of multicystic kidney disease (MKD) and its association with chronic kidney disease (CKD).

Methods

This was a retrospective single-center cohort study. Thirty-one patients showing pathogenic or likely pathogenic variants in COL4A3 or COL4A4 from a cohort of 79 patients with persistent microscopic hematuria were included. Mean follow-up was 9.4 ± 9.6 years. The primary objective of the study was to determine the prevalence of MKD in the cohort of ADAS patients. Secondary objectives were to determine risk factors associated with an estimated glomerular filtration rate (eGFR) <45 mL/min/1.73 m2 at the time of genetic and radiologic evaluation and to investigate the coexistence of other genetic abnormalities associated with familial hematuria and cystic kidney disease.

Results

MKD was found in 16 patients (52%). Mean number of cysts per kidney was 12.7 ± 5.5. No genetic abnormalities were found in a panel of 101 other genes related to familial hematuria, focal segmental glomerulosclerosis and cystic kidney disease. A greater number of patients with MKD had an eGFR <45 mL/min/1.73 m2 (63% vs 7%, P = .006) and more advanced CKD than patients without MKD. The annual rate of eGFR decline was greater in patients with MKD: –1.8 vs 0.06 mL/min/1.73 m2/year (P = .009). By multivariable linear regression analysis, the main determinants of eGFR change per year were time-averaged proteinuria (P = .002) and MKD (P = .02).

Conclusion

MKD is commonly found in ADAS and is associated with a worse kidney outcome. No pathogenic variants were found in genes other than COL4A3/COL4A4.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nephritis, HereditaryPhenotypeRenal Insufficiency, ChronicCollagen Type IVGlomerular Filtration RateHumansFemaleMaleRetrospective StudiesAdultFollow-Up StudiesMiddle AgedAutoantigensPrognosisKidney Diseases, CysticPrevalence

Stichwörter der Autor:innen

autosomal dominant Alport syndromechronic kidney diseasemulticystic kidney disease

Substanzen

Collagen Type IVtype IV collagen alpha3 chainCOL4A4 protein, humanAutoantigens

Autor:innen und Institutionen

  • Department of Nephrology, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Department of Genetics, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Department of Radiology, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Department of Pathology, Hospital General Universitario, Gregorio Marañón, Madrid, Spain.
  • Department of Pathology, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Department of Nephrology, Hospital Fundación Alcorcón, Madrid, Spain.

ORCID-Profile: Hernando Trujillo, Amir Shabaka, Fernando Caravaca-Fontán, Manuel Praga

Förderung

  • Sociedad Española de Nefrología

Zitieren

APA

Bada-Bosch, T., Sevillano, A. M., Sánchez-Calvin, M. T., Palma-Milla, C., Alba de Cáceres, I., Díaz-Crespo, F., Trujillo, H., Alonso, M., Cases-Corona, C., Shabaka, A., Quesada-Espinosa, J. F., Lezana-Rosales, J. M., Gutiérrez, E., Fernández-Juárez, G., Caravaca-Fontán, F., & Praga, M. (2024). Cystic phenotype and chronic kidney disease in autosomal dominant Alport syndrome. Nephrology Dialysis Transplantation, 39(8), 1288-1298. https://doi.org/10.1093/ndt/gfae002

Vancouver

Bada-Bosch T, Sevillano AM, Sánchez-Calvin MT, Palma-Milla C, Alba de Cáceres I, Díaz-Crespo F, et al. Cystic phenotype and chronic kidney disease in autosomal dominant Alport syndrome. Nephrology Dialysis Transplantation. 2024;39(8):1288-1298. doi:10.1093/ndt/gfae002

BibTeX
@article{BadaBosch2024,
  author = {Bada-Bosch, Teresa and Sevillano, Angel M and Sánchez-Calvin, María Teresa and Palma-Milla, Carmen and Alba de Cáceres, Ignacio and Díaz-Crespo, Francisco and Trujillo, Hernando and Alonso, Marina and Cases-Corona, Clara and Shabaka, Amir and Quesada-Espinosa, Juan Francisco and Lezana-Rosales, José Miguel and Gutiérrez, Eduardo and Fernández-Juárez, Gema and Caravaca-Fontán, Fernando and Praga, Manuel},
  title = {Cystic phenotype and chronic kidney disease in autosomal dominant Alport syndrome},
  journal = {Nephrology Dialysis Transplantation},
  year = {2024},
  volume = {39},
  number = {8},
  pages = {1288--1298},
  doi = {10.1093/ndt/gfae002}
}
Kostenlos starten →